It’s back, Duluth! Your chance to score incredible local deals is here again! The Seize the Deal Auction returns starting ...

Powered by a four-stroke, three-cylinder, liquid-cooled engine, the XU 850 delivers 48 lb-ft of torque, 2,000-pound towing ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Argo Living Soils Corp. ( (TSE:ARGO)) has ...

Don’t buy a new bike! Our editors reveal 5 smart tweaks to instantly drop bike weight and boost your road or gravel speed.

This month, we saw the Argo Blockchain plc (LON:ARB) up an impressive 183%. But that doesn't change the fact that the returns over the last three years have been stomach churning. To wit, the share ...

Way back in 2016, we featured a nifty Kickstarter for a kit that converted a regular bicycle into a front-loader cargo hauler in double quick time. Now the company has announced an updated version ...

AMSTERDAM—Calrec introduced a 48-faced Argo M and showcased its largest Argo software updates at the recently concluded IBC2025. Completing the Argo M range and the Argo family, the new console ...

Tires degrade naturally over time and suffer even more damage from potholes, glass, nails or other debris you may run over. If you maintain your tires by keeping them inflated, getting them rotated ...

An Argo CD vulnerability allows API tokens with even low project-level get permissions to access API endpoints and retrieve all repository credentials associated with the project. The flaw, tracked ...

Sept 3 (Reuters) - Swiss drugmaker Novartis (NOVN.S), opens new tab has signed an up to $5.2 billion licensing and options deal with Argo Biopharmaceutical for its experimental candidates that target ...

Entrepreneur Mary Jane Loevlie grew up in Idaho Springs and has started more than 20 businesses from Clear Creek County. She’s hoping the Mighty Argo gondola and mountain top plaza will cement a ...

Novartis has returned to Argo Biopharmaceutical with $160 million in upfront cash to explore various cardiovascular meds in the Chinese biotech’s siRNA pipeline. The latest deal will allow Novartis to ...